Cargando…
Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report
RATIONALE: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse events have been associated with alemtuzumab, including renal-limited anti-glomerular basement membrane (GBM) disease. PRESENTING CONCERN: A 5...
Autores principales: | Harrigan, Amye M., West, Michael L., Geldenhuys, Laurette, Poyah, Penelope |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573726/ https://www.ncbi.nlm.nih.gov/pubmed/33117548 http://dx.doi.org/10.1177/2054358120962680 |
Ejemplares similares
-
Educational Case: Antiglomerular Basement Membrane Disease as an Example of Antibody-Mediated Glomerulonephritis
por: Jebakumar, Deborah, et al.
Publicado: (2020) -
Transformation of membranous nephropathy into antiglomerular-basement membrane glomerluonephritis
por: Szeki, Iren, et al.
Publicado: (2011) -
The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease
por: Yamashita, Marina, et al.
Publicado: (2023) -
Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report
por: Poyah, Penelope, et al.
Publicado: (2021) -
Atypical Noncrescentic Antiglomerular Basement Membrane Disease With Concurrent Thin Basement Membrane Nephropathy
por: Singhal, Pooja, et al.
Publicado: (2018)